Cite
HARVARD Citation
Zanotti, G. et al. (n.d.). 171P Treatment (tx) patterns of patients with advanced renal cell carcinoma (aRCC) receiving first-line (1L) tx: Results from a cross-sectional real-world study. Annals of oncology. p. . [Online].